\-\ Texto\\:\\ \ \(0\)\
\-\ negative\ \(599\)\
\-\ no\\ treatment\\.\ \(2\)\
\-\ high\\ signal\\ intensity\\ expansile\\ lesion\\ right\\ petrous\\ apex\\.\ \(0\)\
\-\ no\\ associated\\ enhancement\ \(0\)\
\-\ cholesterol\\ granuloma\ \(3\)\
\-\ assymetric\\ fatty\\ marrow\\:\\ non\\-expansile\ \(0\)\
\-\ congenital\\ cholesteatoma\\ of\\ the\\ petrous\\ apex\\:\\ low\\ to\\ intermediate\\ signal\\ on\\ t1\ \(0\)\
\-\ trapped\\ fluid\\ within\\ petrous\\ apex\\:\\ low\\ to\\ intermediate\\ signal\\ on\\ t1\ \(0\)\
\-\ apical\\ petrositis\\:\\ low\\ signal\\ on\\ t1\\,\\ psot\\-contrast\\ thick\\ enhancing\\ rim\\.\ \(0\)\
\-\ 13\\ year\\ old\\ female\\ in\\ a\\ mva\\ 6\\ years\\ ago\\.\\ \\ she\\ was\\ found\\ to\\ have\\ an\\ expansile\\ lesion\\ on\\ ct\\ scan\\ done\\ at\\ that\\ time\\.\\ \\ lesion\\ has\\ been\\ followed\\ with\\ mri\\ and\\ found\\ to\\ be\\ stable\\ ever\\ since\\ that\\ time\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ petrous\\:\\ 0\\.3768061303889933\ \(0\)\
\-\ apex\\:\\ 0\\.3132850245379302\ \(0\)\
\-\ expansile\\:\\ 0\\.301620772826065\ \(0\)\
\-\ signal\\:\\ 0\\.25194084143911755\ \(0\)\
\-\ intermediate\\:\\ 0\\.22698547094993818\ \(0\)\
\-\ t1\\:\\ 0\\.20768578335683818\ \(0\)\
\-\ low\\:\\ 0\\.1912668938934461\ \(0\)\
\-\ petrositis\\:\\ 0\\.17768939004313733\ \(0\)\
\-\ lesion\\:\\ 0\\.159806097129548\ \(0\)\
\-\ assymetric\\:\\ 0\\.14448412872331623\ \(0\)\
\-\ ever\\:\\ 0\\.14448412872331623\ \(0\)\
\-\ found\\:\\ 0\\.1437867213494281\ \(0\)\
\-\ cholesteatoma\\:\\ 0\\.13978674900282298\ \(0\)\
\-\ trapped\\:\\ 0\\.1384428986490027\ \(0\)\
\-\ on\\:\\ 0\\.13422874386966546\ \(0\)\
\-\ time\\:\\ 0\\.13171562863852518\ \(0\)\
\-\ cholesterol\\:\\ 0\\.12308524386726012\ \(0\)\
\-\ apical\\:\\ 0\\.1142278455235867\ \(0\)\
\-\ to\\:\\ 0\\.1111093216584432\ \(0\)\
\-\ fatty\\:\\ 0\\.10559504376784845\ \(0\)\
\-\ thick\\:\\ 0\\.10559504376784845\ \(0\)\
\-\ mva\\:\\ 0\\.1020838851435648\ \(0\)\
\-\ granuloma\\:\\ 0\\.10054025760868833\ \(0\)\
\-\ that\\:\\ 0\\.0964353153662617\ \(0\)\
\-\ marrow\\:\\ 0\\.09233581776038148\ \(0\)\
\-\ rim\\:\\ 0\\.0884825472783875\ \(0\)\
\-\ done\\:\\ 0\\.08838291481357315\ \(0\)\
\-\ stable\\:\\ 0\\.08789225651697678\ \(0\)\
\-\ 13\\:\\ 0\\.08379944246098982\ \(0\)\
\-\ ago\\:\\ 0\\.08129692823765786\ \(0\)\
\-\ since\\:\\ 0\\.08048522310645252\ \(0\)\
\-\ congenital\\:\\ 0\\.07983372075465199\ \(0\)\
\-\ intensity\\:\\ 0\\.07889558899424119\ \(0\)\
\-\ followed\\:\\ 0\\.0750313621271446\ \(0\)\
\-\ no\\:\\ 0\\.07226354203064723\ \(0\)\
\-\ enhancing\\:\\ 0\\.06960390672661143\ \(0\)\
\-\ negative\\:\\ 0\\.0687875619262265\ \(0\)\
\-\ years\\:\\ 0\\.06810906255927435\ \(0\)\
\-\ she\\:\\ 0\\.0661412517209705\ \(0\)\
\-\ scan\\:\\ 0\\.06592044493400251\ \(0\)\
\-\ been\\:\\ 0\\.0647340578823752\ \(0\)\
\-\ fluid\\:\\ 0\\.06415257874943506\ \(0\)\
\-\ enhancement\\:\\ 0\\.06395309385905336\ \(0\)\
\-\ high\\:\\ 0\\.0631477545943066\ \(0\)\
\-\ associated\\:\\ 0\\.058563404711283545\ \(0\)\
\-\ mri\\:\\ 0\\.057034115126559135\ \(0\)\
\-\ have\\:\\ 0\\.05550563680839192\ \(0\)\
\-\ female\\:\\ 0\\.05361579366886763\ \(0\)\
\-\ treatment\\:\\ 0\\.05292768141861016\ \(0\)\
\-\ within\\:\\ 0\\.051173929425535954\ \(0\)\
\-\ has\\:\\ 0\\.05075189944744502\ \(0\)\
\-\ be\\:\\ 0\\.04507296403537965\ \(0\)\
\-\ an\\:\\ 0\\.04248816547602191\ \(0\)\
\-\ ct\\:\\ 0\\.042300694304079206\ \(0\)\
\-\ at\\:\\ 0\\.04196772714641283\ \(0\)\
\-\ was\\:\\ 0\\.038723002886307006\ \(0\)\
\-\ right\\:\\ 0\\.03683762681163327\ \(0\)\
\-\ year\\:\\ 0\\.034241974425636514\ \(0\)\
\-\ old\\:\\ 0\\.03288414860221317\ \(0\)\
\-\ in\\:\\ 0\\.027640610451838913\ \(0\)\
\-\ and\\:\\ 0\\.022959561412204694\ \(0\)\
\-\ the\\:\\ 0\\.022170509878572716\ \(0\)\
\-\ with\\:\\ 0\\.0217567651998916\ \(0\)\
\-\ of\\:\\ 0\\.021743773300525793\ \(0\)\
